Literature DB >> 22285193

Neuregulin-1/ErbB signaling is impaired in the rat model of diabetic cardiomyopathy.

Chun Gui1, Liguang Zhu, Ming Hu, Lei Lei, Qicheng Long.   

Abstract

BACKGROUND: Diabetic cardiomyopathy (DCP) is one of the leading causes of increased morbidity and mortality in the diabetic population. The neuregulin-1(NRG1)/ErbB signal system plays a critical role in maintenance of adult heart function. But little is known about the changes of NRG1/ErbB signal system in DCP. The aim of this study was to investigate the changes of the NRG1/ErbB signal system in DCP.
METHODS: A rat model of DCP was established using a single intraperitoneal injection of streptozotocin (STZ). Cardiac function was assessed using echocardiography. The left ventricle fibrosis was evaluated using Masson's trichrome staining. The mRNA expression profiles of ErbB2 and ErbB4 receptors were evaluated using real-time polymerase chain reaction. The protein expression of NRG1 and the phosphorylation of ErbB2 and ErbB4 receptors were assessed using Western blot analysis.
RESULTS: The results showed dramatic left ventricle fibrosis and impaired left ventricle systolic function at 12 weeks after STZ-induced diabetes. This study also showed that ErbB2 and ErbB4 mRNA expression and NRG1 protein expression in the left ventricular myocardium were significantly decreased. In addition, we observed decreased phosphorylation of the ErbB2 and ErbB4 receptors at 12 weeks after the induction of diabetes.
CONCLUSIONS: These findings suggest that NRG1/ErbB signaling is impaired in DCP, which may play some roles in the pathogenesis of DCP.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22285193     DOI: 10.1016/j.carpath.2011.12.006

Source DB:  PubMed          Journal:  Cardiovasc Pathol        ISSN: 1054-8807            Impact factor:   2.185


  17 in total

Review 1.  Signalling between microvascular endothelium and cardiomyocytes through neuregulin.

Authors:  Emily M Parodi; Bernhard Kuhn
Journal:  Cardiovasc Res       Date:  2014-01-29       Impact factor: 10.787

2.  Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.

Authors:  Leni Vandekerckhove; Zarha Vermeulen; Zhi Zhao Liu; Sonia Boimvaser; Andreas Patzak; Vincent F M Segers; Gilles W De Keulenaer
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-01-19       Impact factor: 4.310

3.  Phenotype-Specific Association of Single-Nucleotide Polymorphisms with Heart Failure and Preserved Ejection Fraction: a Genome-Wide Association Analysis of the Cardiovascular Health Study.

Authors:  David P Kao; Laura M Stevens; Michael A Hinterberg; Carsten Görg
Journal:  J Cardiovasc Transl Res       Date:  2017-01-19       Impact factor: 4.132

Review 4.  Neuregulin as a heart failure therapy and mediator of reverse remodeling.

Authors:  Cristi L Galindo; Sergey Ryzhov; Douglas B Sawyer
Journal:  Curr Heart Fail Rep       Date:  2014-03

Review 5.  Neuregulin in cardiovascular development and disease.

Authors:  Oghenerukevwe Odiete; Michael F Hill; Douglas B Sawyer
Journal:  Circ Res       Date:  2012-10-26       Impact factor: 17.367

Review 6.  Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.

Authors:  Joerg Herrmann; Eric H Yang; Cezar A Iliescu; Mehmet Cilingiroglu; Konstantinos Charitakis; Abdul Hakeem; Konstantinos Toutouzas; Massoud A Leesar; Cindy L Grines; Konstantinos Marmagkiolis
Journal:  Circulation       Date:  2016-03-29       Impact factor: 29.690

7.  Neuregulin-1β Plays a Neuroprotective Role by Inhibiting the Cdk5 Signaling Pathway after Cerebral Ischemia-Reperfusion Injury in Rats.

Authors:  Rui Zhang; Cui Liu; Yaqing Ji; Lei Teng; Yunliang Guo
Journal:  J Mol Neurosci       Date:  2018-09-11       Impact factor: 3.444

8.  MOTS-c and Exercise Restore Cardiac Function by Activating of NRG1-ErbB Signaling in Diabetic Rats.

Authors:  Shunchang Li; Manda Wang; Jiacheng Ma; Xiaoli Pang; Jinghan Yuan; Yanrong Pan; Yu Fu; Ismail Laher
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-17       Impact factor: 5.555

9.  Type 1 diabetes mellitus abrogates compensatory augmentation of myocardial neuregulin-1β/ErbB in response to myocardial infarction resulting in worsening heart failure.

Authors:  Oghenerukevwe Odiete; Ewa A Konik; Douglas B Sawyer; Michael F Hill
Journal:  Cardiovasc Diabetol       Date:  2013-03-27       Impact factor: 9.951

10.  Impairment of endothelial-myocardial interaction increases the susceptibility of cardiomyocytes to ischemia/reperfusion injury.

Authors:  Thorsten M Leucker; Zhi-Dong Ge; Jesse Procknow; Yanan Liu; Yang Shi; Martin Bienengraeber; David C Warltier; Judy R Kersten
Journal:  PLoS One       Date:  2013-07-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.